前收市價 | 7.90 |
開市 | 9.17 |
買盤 | 9.20 |
賣出價 | 10.90 |
拍板 | 70.00 |
到期日 | 2025-01-17 |
今日波幅 | 9.17 - 9.17 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 3.44k |
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
Higher business-to-business sales aid Inogen's (INGN) overall first-quarter results.
QuidelOrtho's (QDEL) first-quarter results reflect growth in revenues, excluding the COVID-19 revenue impact.